These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30627939)

  • 1. What Does it Take to Make Model-Informed Precision Dosing Common Practice? Report from the 1st Asian Symposium on Precision Dosing.
    Polasek TM; Rostami-Hodjegan A; Yim DS; Jamei M; Lee H; Kimko H; Kim JK; Nguyen PTT; Darwich AS; Shin JG
    AAPS J; 2019 Jan; 21(2):17. PubMed ID: 30627939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Dynamic Prescribing Information: Codevelopment of Companion Model-Informed Precision Dosing Tools in Drug Development.
    Polasek TM; Rayner CR; Peck RW; Rowland A; Kimko H; Rostami-Hodjegan A
    Clin Pharmacol Drug Dev; 2019 May; 8(4):418-425. PubMed ID: 30500115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy.
    Darwich AS; Polasek TM; Aronson JK; Ogungbenro K; Wright DFB; Achour B; Reny JL; Daali Y; Eiermann B; Cook J; Lesko L; McLachlan AJ; Rostami-Hodjegan A
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():225-245. PubMed ID: 33035445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model-Informed Precision Dosing Using Machine Learning for Levothyroxine in General Practice: Development, Validation and Clinical Simulation Trial.
    Janssen Daalen JM; Doesburg D; Hunik L; Kessel R; Herngreen T; Knol D; Ruys T; van den Bemt BJF; Schers HJ
    Clin Pharmacol Ther; 2024 Sep; 116(3):824-833. PubMed ID: 38711388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial Intelligence and Machine Learning Approaches to Facilitate Therapeutic Drug Management and Model-Informed Precision Dosing.
    Poweleit EA; Vinks AA; Mizuno T
    Ther Drug Monit; 2023 Apr; 45(2):143-150. PubMed ID: 36750470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing-Using Rifampicin as an Example.
    Keutzer L; Simonsson USH
    Front Pharmacol; 2020; 11():794. PubMed ID: 32536870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics.
    Wicha SG; Märtson AG; Nielsen EI; Koch BCP; Friberg LE; Alffenaar JW; Minichmayr IK;
    Clin Pharmacol Ther; 2021 Apr; 109(4):928-941. PubMed ID: 33565627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future.
    Darwich AS; Ogungbenro K; Vinks AA; Powell JR; Reny JL; Marsousi N; Daali Y; Fairman D; Cook J; Lesko LJ; McCune JS; Knibbe C; de Wildt SN; Leeder JS; Neely M; Zuppa AF; Vicini P; Aarons L; Johnson TN; Boiani J; Rostami-Hodjegan A
    Clin Pharmacol Ther; 2017 May; 101(5):646-656. PubMed ID: 28182269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis.
    Faelens R; Wang Z; Bouillon T; Declerck P; Ferrante M; Vermeire S; Dreesen E
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-informed precision dosing: State of the art and future perspectives.
    Minichmayr IK; Dreesen E; Centanni M; Wang Z; Hoffert Y; Friberg LE; Wicha SG
    Adv Drug Deliv Rev; 2024 Aug; 215():115421. PubMed ID: 39159868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulating clinical trials for model-informed precision dosing: using warfarin treatment as a use case.
    Augustin D; Lambert B; Robinson M; Wang K; Gavaghan D
    Front Pharmacol; 2023; 14():1270443. PubMed ID: 37927586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis.
    Centanni M; van de Velde ME; Uittenboogaard A; Kaspers GJL; Karlsson MO; Friberg LE
    Clin Pharmacokinet; 2024 Feb; 63(2):197-209. PubMed ID: 38141094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children's Hospital.
    Frymoyer A; Schwenk HT; Zorn Y; Bio L; Moss JD; Chasmawala B; Faulkenberry J; Goswami S; Keizer RJ; Ghaskari S
    Front Pharmacol; 2020; 11():551. PubMed ID: 32411000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data.
    Kluwe F; Michelet R; Huisinga W; Zeitlinger M; Mikus G; Kloft C
    Clin Pharmacokinet; 2023 Oct; 62(10):1461-1477. PubMed ID: 37603216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-Informed Precision Dosing Software Tools for Dosage Regimen Individualization: A Scoping Review.
    Del Valle-Moreno P; Suarez-Casillas P; Mejías-Trueba M; Ciudad-Gutiérrez P; Guisado-Gil AB; Gil-Navarro MV; Herrera-Hidalgo L
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-Informed Precision Dosing of Antibiotics in Pediatric Patients: A Narrative Review.
    Abdulla A; Edwina EE; Flint RB; Allegaert K; Wildschut ED; Koch BCP; de Hoog M
    Front Pediatr; 2021; 9():624639. PubMed ID: 33708753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A continued learning approach for model-informed precision dosing: Updating models in clinical practice.
    Maier C; de Wiljes J; Hartung N; Kloft C; Huisinga W
    CPT Pharmacometrics Syst Pharmacol; 2022 Feb; 11(2):185-198. PubMed ID: 34779144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which patients benefit from model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin at the ICU?
    Ewoldt TMJ; Abdulla A; Rietdijk WJR; Hunfeld N; Muller AE; Endeman H; Koch BCP;
    Int J Antimicrob Agents; 2023 Oct; 62(4):106931. PubMed ID: 37482257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case Study.
    Uster DW; Stocker SL; Carland JE; Brett J; Marriott DJE; Day RO; Wicha SG
    Clin Pharmacol Ther; 2021 Jan; 109(1):175-183. PubMed ID: 32996120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalised antimicrobial dosing: standing on the shoulders of giants.
    Wallenburg E; Ter Heine R; Schouten JA; Brüggemann RJM
    Int J Antimicrob Agents; 2020 Sep; 56(3):106062. PubMed ID: 32574792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.